8.00% p.a. Multi Barrier Reverse Convertible
Astrazeneca, GlaxoSmithKline, Sanofi
Valor
142107374
SIX Symbol
QQHRCH
ISIN
CH1421073748
Identifiers
142107374
CH1421073748
QQHRCH
Yield Enhancement
Barrier Reverse Convertible
Callable Multi Barrier Reverse Convertible
1230
Parameters
Raiffeisen Switzerland Cooperative, St. Gallen, Switzerland
Quarterly
8.00% p.a.
Cash Settlement
Dirty (accrued interest included)
100%
CHF 1'000.00
CHF
Listed
Yes
Life Cycle
1.5 Years
13 Jun 2025
20 Jun 2025
20 Jun 2025
30 Jun 2025
30 Jun 2025
23 Dec 2026
30 Dec 2026
Barrier
69.00%
Continuous barrier observation (american)
20 Jun 2025 - 23 Dec 2026
No
Product Specific Features
100.00%
Performance
Name Market Price
{{ underlyings['67109514'].currency }} {{ underlyings['67109514'].underlyingFeed.spot | number:2 }}
{{ underlyings['67109504'].currency }} {{ underlyings['67109504'].underlyingFeed.spot | number:2 }}
{{ underlyings['67109411'].currency }} {{ underlyings['67109411'].underlyingFeed.spot | number:2 }}
Coupons
Payment Date Amount
30 Sep 2025 2.00%
05 Jan 2026 2.00%
30 Mar 2026 2.00%
30 Jun 2026 2.00%
30 Sep 2026 2.00%
30 Dec 2026 2.00%
Early Redemption
Observation Date Redemption Amount
23 Jun 2026 100.00%
23 Sep 2026 100.00%
Astrazeneca
Astrazeneca
{{ underlyings['67109514'].currency }} {{ underlyings['67109514'].underlyingFeed.spot | number:2 }}
AZN LN
GBp
London Stock Exchange
GlaxoSmithKline
GlaxoSmithKline
{{ underlyings['67109504'].currency }} {{ underlyings['67109504'].underlyingFeed.spot | number:2 }}
GSK LN
GBp
London Stock Exchange
Sanofi
Sanofi
{{ underlyings['67109411'].currency }} {{ underlyings['67109411'].underlyingFeed.spot | number:2 }}
SAN FP
EUR
Euronext Paris